MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

Search

West Pharmaceutical Services Inc

Închisă

SectorSănătate

274.96 -1.29

Rezumat

Modificarea prețului

24h

Curent

Minim

271.32

Maxim

282.53

Indicatori cheie

By Trading Economics

Venit

8.2M

140M

Vânzări

38M

804M

P/E

Medie Sector

41.338

87.826

Randament dividend

0.3

Marjă de profit

17.406

Angajați

10,600

EBITDA

19M

217M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+25.23% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.30%

2.26%

Următoarele câștiguri

12 feb. 2026

Data viitoare de dividende

4 feb. 2026

Următoarea dată ex-dividende

28 ian. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

307M

20B

Deschiderea anterioară

276.25

Închiderea anterioară

274.96

Sentimentul știrilor

By Acuity

34%

66%

111 / 372 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

West Pharmaceutical Services Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

8 ian. 2026, 23:08 UTC

Achiziții, Fuziuni, Preluări

Rio Tinto, Glencore in Talks to Form World's Biggest Miner -- 3rd Update

8 ian. 2026, 21:39 UTC

Achiziții, Fuziuni, Preluări

Glencore, Rio Tinto Restart Merger Talks -- 2nd Update

8 ian. 2026, 20:54 UTC

Achiziții, Fuziuni, Preluări

Glencore, Rio Tinto Restart Merger Talks -- Update

8 ian. 2026, 20:44 UTC

Achiziții, Fuziuni, Preluări

Glencore, Rio Tinto Restart Merger Talks

8 ian. 2026, 17:05 UTC

Achiziții, Fuziuni, Preluări

Chinese Anta Sports Products Offers to Buy Pinault Family's Stake in Puma, Reuters Says, Citing Unnamed Sources

8 ian. 2026, 16:43 UTC

Principalele dinamici ale pieței

Babcock & Wilcox Shares Rise on Siemens Deal for Data Center Project

8 ian. 2026, 23:44 UTC

Market Talk

Nikkei May Rise on Weaker Yen -- Market Talk

8 ian. 2026, 23:37 UTC

Market Talk

Gold Steady, Underpinned by Geopolitical Risks -- Market Talk

8 ian. 2026, 22:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8 ian. 2026, 22:42 UTC

Market Talk

RBA Still Battling a Troubling Inflation Outlook, Says TD -- Market Talk

8 ian. 2026, 22:30 UTC

Achiziții, Fuziuni, Preluări

Glencore, Rio Tinto Confirm Early Merger Talks -- Barrons.com

8 ian. 2026, 21:53 UTC

Câștiguri

These Stocks Moved the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8 ian. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

8 ian. 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

8 ian. 2026, 21:10 UTC

Achiziții, Fuziuni, Preluări

Rio Tinto Says Current Expectation That Any Deal Would Involve Buying Glencore Via Scheme of Arrangement

8 ian. 2026, 21:09 UTC

Market Talk

Oil Rises As Trump Said to Back Russia Sanctions Bill -- Market Talk

8 ian. 2026, 21:09 UTC

Achiziții, Fuziuni, Preluări

Rio Tinto Confirms in Talks With Glencore Over Possible Merger

8 ian. 2026, 20:21 UTC

Market Talk

U.S. Natural Gas Futures Down Despite Inventory Draw -- Market Talk

8 ian. 2026, 19:44 UTC

Market Talk

Gold's Shine Masks Deep Drops in Canada Steel, Aluminum Exports -- Market Talk

8 ian. 2026, 18:50 UTC

Market Talk

Mexico's Industrial Production Seen Lower in November -- Market Talk

8 ian. 2026, 17:48 UTC

Câștiguri

These Stocks Are Moving the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8 ian. 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

8 ian. 2026, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

8 ian. 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

8 ian. 2026, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8 ian. 2026, 16:45 UTC

Market Talk

Goldman Lifts 1H LME Copper Forecast -- Market Talk

8 ian. 2026, 16:03 UTC

Market Talk

Global Equities Roundup: Market Talk

8 ian. 2026, 16:03 UTC

Market Talk

Currency Markets Could Be Underpricing Medium-Term Risks -- Market Talk

8 ian. 2026, 16:02 UTC

Market Talk

U.S. Natural Gas Inventories Fall As Expected -- Market Talk

8 ian. 2026, 15:23 UTC

Achiziții, Fuziuni, Preluări

Paramount Defends Its Hostile Bid for Warner -- Update

Comparație

Modificare preț

West Pharmaceutical Services Inc Așteptări

Obiectiv de preț

By TipRanks

25.23% sus

Prognoză pe 12 luni

Medie 348.7 USD  25.23%

Maxim 375 USD

Minim 285 USD

În baza a 12 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruWest Pharmaceutical Services Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

12 ratings

10

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

213.26 / 219.27Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

111 / 372 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat